LFR a bacterium (MRSA, yellow) being ingested by an immune cell (Neutrophil, purple)LFR lung cancer cell during cell divisionMoores Cancer Center


NCI logoOne revolutionary building brings together research, education, and clinical care where our clinicians and scientists advance patient care through translational research. As an NCI-designated comprehensive cancer center, Moores Cancer Center is at the forefront of the fight against cancer. From research in molecular genetics to the most advanced clinical treatments, we are developing promising new therapies and making them available to cancer patients throughout the region. Read More >

Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes

Glioblastoma is an aggressive form of brain cancer that infiltrates surrounding brain tissue, making it extremely difficult to treat with surgery. Even when chemotherapy and radiation successfully destroy the bulk of a patient’s glioblastoma cells, they may not affect the cancer stem cells. Researchers at University of California San Diego School of Medicine led by Jeremy Rich, MD, discovered that by reaching stem cells at the tumor’s root, multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice. Read more in press release.